Intuitive Surgical, Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- David J. Rosa
- Full Time Employees
- 17,021
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 1020 Kifer Road Sunnyvale CA United States 94086-5304
- IPO Date
- Jun 13, 2000
- CIK
- 0001035267
- Website
- intuitive.com
- Similar Companies
- Business
- Intuitive Surgical, Inc. develops, manufactures, and markets advanced robotic-assisted surgical systems designed to enhance the quality and access to minimally invasive care globally. Its core products include the da Vinci Surgical System, which enables surgeons to perform a wide range of complex surgical procedures across specialties such as general surgery, urology, gynecology, cardiothoracic, and head and neck surgery using minimally invasive techniques. The company also offers the Ion Endoluminal System, a robotic platform for diagnostic endoluminal procedures enabling minimally invasive lung biopsies through advanced imaging and navigation technology. Intuitive’s product suite includes stapling, energy, and core instrumentation compatible with its multi-port da Vinci systems, alongside progressive learning pathways that facilitate clinical adoption, and a comprehensive infrastructure of service and support including installation, maintenance, technical support, proactive system health monitoring, and integrated digital capabilities that provide hospitals with data-driven insights to optimize surgical performance. Founded in 1995 and headquartered in Sunnyvale, California, Intuitive Surgical operates globally, supporting hospitals and surgical teams across over 60 countries. In the last 1-2 years, the company has advanced the commercial launch of its da Vinci 5 Surgical System, receiving regulatory clearances from the US FDA and CE mark in 2024, with 2025 focused on scaling the adoption of this platform through enhanced hardware and software upgrades featuring increased computing power and digital capabilities. Intuitive reported significant growth in system placements and procedure volumes, with a 14% year-over-year increase in installed base and 17% procedural growth as of mid-2025. Strategic priorities include expanding its robotic surgery ecosystem, reinforcing its recurring revenue model—which accounted for 84% of revenue in 2024—and furthering its Quintuple Aim framework aimed at improving patient outcomes, care team experience, access to care, and lowering total costs. Additionally, leadership transitioned in mid-2025 with President Dave Rosa promoted to CEO, signaling a new phase of growth and innovation focus. Despite rising competition in the robotic surgery field, Intuitive remains a dominant market leader through continuous technological innovation and strategic expansion. This comprehensive offering positions Intuitive Surgical as a pioneer and global leader in robotic-assisted, minimally invasive surgical technology, serving healthcare providers with products, services, and digital innovations that collectively enhance surgical precision, patient recovery, and overall healthcare system efficiency.
Company News
2 Healthcare Stocks to Buy After Crushing Q3 Earnings Expectations: ELV & ISRG
ISRG Q3 Earnings Call Highlights Pricing and Growth Strategy
Intuitive Surgical: 3 Key Takeaways for Long-Term Investors
Intuitive Surgical Q3: The Best Way To Grow May Be To Charge Less
Intuitive Surgical's Q3 Earnings Beat Estimates on Strong System Sales
Intuitive Surgical, Inc. (ISRG) Crossed Above the 200-Day Moving Average: What That Means for Investors
These Analysts Revise Their Forecasts On Intuitive Surgical After Q3 Results
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Applied Digital, Chipotle Mexican Grill, Cirrus Logic, Costco, Digital Realty Trust, Intuitive Surgical, Netflix, Robinhood Markets, Zscaler, and More
Intuitive Surgical Stock Falls Despite da Vinci 5 Placements Jump
Intuitive Surgical Inc (ISRG) (Q3 2026) Earnings Call Highlights: Revenue Jumps 22% to $3 Billion as Procedure Growth and Record Placements Offset Pricing Headwinds
Intuitive Surgical, Inc. (ISRG) Q3 2026 Earnings Call Transcript
What Intuitive Surgical (ISRG) Said on Its Q3 Earnings Call
Intuitive Surgical (ISRG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Intuitive Surgical, Inc. (ISRG) Q3 Earnings and Revenues Top Estimates
Intuitive Surgical Stock Slides Despite Earnings Beat as Company Discloses Settlement
How Did Intuitive Surgical Inc (ISRG) Perform in Q3? EPS of $1.49 Beats Analyst Estimates; GF Score: 96/100, 31.1% Undervalued
Intuitive Announces Third Quarter Earnings
Why ISRG Is Lowering Instrument Costs Despite Strong Profitability
Breakfast News: A One-Line Fix Could Shake Up AI
3 Wall Street Analysts See Intuitive Surgical Hitting $500. Here's the Bull Case.